Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eaton Vance Ohio Municipal Income Trust (NQ: EVO ) 3.770 +0.060 (+1.62%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Eaton Vance Ohio Municipal Income Trust < Previous 1 2 3 4 Next > Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths August 13, 2024 Via ACCESSWIRE Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb August 12, 2024 Via ACCESSWIRE Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb August 07, 2024 Via ACCESSWIRE Evotec SE Reports First Half-year 2024 Results on 14 August 2024 August 07, 2024 Via ACCESSWIRE Evotec SE Provides Guidance Update August 06, 2024 Via ACCESSWIRE Evotec Provides Guidance Update August 06, 2024 Via ACCESSWIRE Evotec and Pfizer Collaborate to Advance Drug Discovery in France July 09, 2024 Via ACCESSWIRE Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz July 08, 2024 Via ACCESSWIRE Evotec Reports Q1 2024 Results and Provides Corporate Update May 21, 2024 Via ACCESSWIRE Evotec SE: Invitation to Conference Call January 21, 2024 Via ACCESSWIRE Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program June 24, 2024 Via ACCESSWIRE Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb June 12, 2024 Via ACCESSWIRE Evotec SE: Results of the Annual General Meeting 2024 June 10, 2024 Via ACCESSWIRE Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases May 29, 2024 Via ACCESSWIRE Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease May 27, 2024 Via ACCESSWIRE Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024 May 15, 2024 Via ACCESSWIRE CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease May 14, 2024 From Centogene NV Via GlobeNewswire Bayer and Evotec Collaborate to Advance Precision Cardiology April 29, 2024 Via ACCESSWIRE Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth April 23, 2024 Via ACCESSWIRE Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer April 23, 2024 Via ACCESSWIRE Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments April 18, 2024 Via ACCESSWIRE Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024 April 17, 2024 Via ACCESSWIRE Evotec welcomes Aurélie Dalbiez as Chief People Officer April 16, 2024 Via ACCESSWIRE Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic March 05, 2024 Via ACCESSWIRE Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV February 06, 2024 Via ACCESSWIRE Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies January 10, 2024 Via ACCESSWIRE Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb January 07, 2024 Via ACCESSWIRE Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I January 03, 2024 Via ACCESSWIRE Evotec Announces CEO Transition January 03, 2024 Via ACCESSWIRE Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes December 18, 2023 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.